Anna Ågren

967 citations
28 papers · 737 · 1 hit paper · h-index 14

Impact in

Papers in

Anna Ågren

28 papers receiving 727 citations

Anna Ågren's Hit Papers

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study 2017 · 239 citations
2390+3+6Years since publication50100150200

Peers

Anna Ågren
Comparison fields: 5 of 59
  • Internal Medicine 182
  • Critical Care and Intensive Care Medicine 199
  • Hematology 140
  • Cardiology and Cardiovascular Medicine 265
  • Biochemistry 48
Replace René van Oerle with:
René van Oerle Netherlands
Hajna Losonczy Hungary
Elias Kyriakou Greece
Roza Chaireti Sweden
Alex Gatt Malta
Geoffrey Kershaw Australia
Martin Doelberg Switzerland
Steven P. Ball United States
Ingrid Škorňová Slovakia
Jayesh Jani United States
Anna Ågren relative to René van Oerle Netherlands René van Oerle's profile →
Citations per field
00.5×1.5×2.5×
René van Oerle · 1×
Citations per year

Countries citing papers authored by Anna Ågren

Since Specialization
Citations

This map shows the geographic impact of Anna Ågren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Ågren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Ågren more than expected).

Fields of papers citing papers by Anna Ågren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Ågren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Ågren. The network helps show where Anna Ågren may publish in the future.

Co-authors

The 25 scholars most cited alongside Anna Ågren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Ågren Line = papers co-authored together Anna Ågren links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
Hit paper breakdown →
2017239
2 201185
3 201555
4 202150
5 201347
6 201243
7 201436
8 201624
9 201923
10 201421
11 201716
12 201514
13 201714
14 201613
15 201713
16 201410
17 20158
18 20226
19 20224
20 20243

About Anna Ågren

Anna Ågren is a scholar working on Critical Care and Intensive Care Medicine, Cardiology and Cardiovascular Medicine, Hematology, Internal Medicine and Epidemiology, having authored 28 papers that have together received 737 indexed citations. Recurring topics across this work include Trauma, Hemostasis, Coagulopathy, Resuscitation (7 papers), Atrial Fibrillation Management and Outcomes (5 papers), Venous Thromboembolism Diagnosis and Management (4 papers), Platelet Disorders and Treatments (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Blood properties and coagulation (2 papers), Hemoglobinopathies and Related Disorders (2 papers) and Hemostasis and retained surgical items (2 papers). The work is most often cited by research in Internal Medicine (182 citations), Critical Care and Intensive Care Medicine (199 citations), Hematology (140 citations), Cardiology and Cardiovascular Medicine (265 citations) and Biochemistry (48 citations). Anna Ågren has collaborated with scholars based in Sweden, Canada and Netherlands. Frequent co-authors include Margareta Holmström, Ammar Majeed, Sam Schulman, Maria Bruzelius, Maria Magnusson, Jacob Odeberg, Roza Chaireti, Tony Frisk, David E. Schmidt and Agneta Wikman. Their work appears in journals such as Thrombosis Research, Thrombosis and Haemostasis, Scandinavian Journal of Clinical and Laboratory Investigation, Haemophilia and Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact